T he European Commission has fined Israeli drugmaker Teva Pharmaceutical Industries (NYSE:TEVA) EUR 462.6M, or around $500M, for trying to ward off competition for its blockbuster multiple ...
The European Commission has delivered a hefty fine to Teva for abusing a dominant position in multiple sclerosis by artificially extending the patent protection for former blockbuster Copaxone.
The European Commission has formally opened an antitrust investigation into Teva, which will assess whether the pharma company illegally delayed launches and use of generic versions of its ...
BRUSSELS (AP) — The European Commission said Thursday it has fined Israeli generic drugmaker Teva more than 460 million euros ($500 million) for improperly seeking to protect the patent for its ...
TEVAN.UL] failed to convince a U.S. appeals court on Friday to reverse a decision that would remove patents related to its ...
Teva expects to launch Austedo in European markets in 2026. In 2024, Teva expects Austedo sales to be approximately $1.6 billion. Uzedy (risperidone) extended-release injectable suspension ...
Dec. 17 (UPI) --The European Commission on Tuesday launched a probe against TikTok for the way it handles elections, particularly in Romania where ultranationalist Calin Georgescu shocked experts ...